Now showing items 1-3 of 3

    • Parra, Mario A.; Orellana, Paulina; León Rodríguez, Tomás Ignacio; Cabello G., Victoria; Henríquez, Fernando; Gómez, Rodrigo; Avalos, Constanza; Damian, Andrés; Slachevsky Chonchol, Andrea María; Ibañez, Augustín; Zetterberg, Henrik; Tijms, Betty M.; Yokoyama, Jennifer S.; Piña Escudero, Stefanie D.; Cochran, J. Nicholas; Matallana, Diana L.; Acosta, Daisy; Allegri, Ricardo; Arias Suárez, Bianca P.; Barra, Bernardo; Behrens Pellegrino, María Isabel Ofelia; Brucki, Sonia M.D.; Busatto, Geraldo; Caramelli, Paulo; Castro Suarez, Sheila; Contreras, Valeria; Custodio, Nilton; Dansilio, Sergio; Cruz Puebla, Myriam de la; Cruz de Souza, Leonardo; Diaz, Mónica M.; Duque, Lissette; Farías Gontupil, Gonzalo Andrés; Ferreira, Sergio T.; Magrath Guimet, Nahuel; Kmaid, Ana; Lira, David; Lopera, Francisco; Mar Meza, Beatriz; Miotto, Eliane C.; Nitrini, Ricardo; Núñez, Alberto; O’Neill, Santiago; Ochoa, John; Pintado Caipa, Maritza; França Resende, Elisa de Paula; Risacher, Shannon; Rojas, Luz Angela; Sabaj, Valentina; Schilling, Lucas; Sellek, Allis F.; Sosa, Ana; Takada, Leonel T.; Teixeira, Antonio L.; Unaucho Pilalumbo, Martha; Durán Aniotz, Claudia (Wiley, 2022)
      Limited knowledge on dementia biomarkers in Latin American and Caribbean (LAC) countries remains a serious barrier. Here, we reported a survey to explore the ongoing work, needs, interests, potential barriers, and opportunities ...
    • Durán Aniotz, Claudia Andrea; Orellana, Paulina; Rodríguez, Tomas León; Henríquez, Fernando; Cabello, Victoria; Aguirre Pinto, María Francisca; Escobedo, Tamara; Takada, Leonel T.; Pina Escudero, Stefanie D.; López, Oscar; Yokoyama, Jennifer S.; Ibáñez, Agustín; Parra, Mario A.; Slachevsky Chonchol, Andrea Maria (Frontiers Media, 2021)
      Frontotemporal dementia (FTD) includes a group of clinically, genetically, and pathologically heterogeneous neurodegenerative disorders, affecting the fronto-insular-temporal regions of the brain. Clinically, FTD is ...
    • Ogonowski, Natalia; Salcidua, Stefanny; León Albarracín, Tomás; Chamorro Veloso, Nayaret; Valls, Cristian; Avalos, Constanza; Bisquertt, Alejandro; Rentería, Miguel E.; Orellana, Paulina; Duran Aniotz, Claudia (Frontiers Media, 2022)
      The rate of progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is estimated at > 10% per year, reaching up to 80-90% after 6 years. MCI is considered an indicator of early-stage AD. In this context, ...